Transcatheter Heart Valve Market To Reach $21.24 Billion By 2033

Transcatheter Heart Valve Market Growth & Trends

The global transcatheter heart valve market size is estimated to reach USD 21.24 billion by 2033, registering to grow at a CAGR of 16.49% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

 Request a free sample copy or view report summary: Transcatheter Heart Valve Market Report

Transcatheter Heart Valve Market Report Highlights

• The transcatheter aortic valve segment holds the largest market share of 81.67% in 2024. The market is divided into transcatheter aortic, pulmonary, and mitral valves.

• The market is categorized by technology into balloon-expanded transcatheter valves and self-expanded transcatheter valves. In 2024, the self-expanded transcatheter valve segment held the largest market share of 63.97%.

• The North America transcatheter heart valve market dominated globally with a 48.30% market share in 2024, driven by advanced healthcare infrastructure, high awareness levels, and strong healthcare spending.

• The Asia Pacific transcatheter heart valve market is experiencing significant growth driven by an increasing number of patients diagnosed with cardiovascular diseases due to changing lifestyles, urbanization, and an aging population.

Transcatheter Heart Valve Market Segmentation

Grand View Research has segmented the global transcatheter heart valve market based on application, technology, and region:

Transcatheter Heart Valve Application Outlook (Revenue, USD Million, 2021 - 2033)

• Transcatheter Aortic Valve

• Transcatheter Pulmonary Valve

• Transcatheter Mitral Valve

Transcatheter Heart Valve Technology Outlook (Revenue, USD Million, 2021 - 2033)

• Balloon Expanded Transcatheter Valve

• Self-Expanded Transcatheter Valve

Transcatheter Heart Valve Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Transcatheter Heart Valve Market

• Medtronic

• Abbott

• Braile Biomédica

• Meril Life Sciences Pvt. Ltd., Inc.

• Edwards Lifesciences Corporation

• MicroPort Scientific Corporation

• Venus Medtech (Hangzhou) Inc.

• JenaValve

• Biosensors International Group, Ltd

• HLT Medical (Bracco)